Alexander Garcia, DO
Emergency Medicine · Miami Beach, FLNPI 1427206358
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $750 of the $1,188 with a category attached, or 63.1%. Johnson & Johnson accounts for 63.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $750 and has fallen 68.3% since, to $238 in 2025. Among emergency medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 11 payments — averaging $108.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$750
- Stryker$159
- Vapotherm Inc$95
- AbbVie$51
- AstraZeneca$31
- Ipsen Biopharmaceuticals, Inc$28
- plus $75 from 4 others
What the payments were for
- Speaking & faculty fees$75063%
- Food & beverage$43837%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $750 |
| Stryker | 1 | $159 |
| Vapotherm Inc | 1 | $95 |
| AbbVie | 2 | $51 |
| AstraZeneca | 1 | $31 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Osprey Medical Inc | 1 | $22 |
| Siemens Medical Solutions USA, Inc. | 1 | $20 |
| Pfizer | 1 | $19 |
| Portola Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,188 in reported general payments places this provider in the 90th percentile of 3,289 emergency medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $334 |
| CefuroximeCefuroxime Axetil | 24 | $276 |
| Cephalexin | 23 | $167 |
| Methylprednisolone | 23 | $163 |
| Metronidazole | 15 | $148 |
| Baclofen | 25 | $87 |
| Azithromycin | 25 | $77 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Miami Beach
- Richard GirouxMiami Beach$6K
- Laurent DreyfussSunrise$1.2M
- Jason WilsonTampa$538K
- Robert LutenJacksonville$190K
- Adam LeisyHialeah$148K
- Joseph TyndallGainesville$130K
- Kunal AgarwalMiami$101K
- Jason WilsonFort Myers$96K
- Latha GantiGainesville$86K
- Brandon AllenGainesville$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.